Important Safety Information Prescribing Information Patient Prescribing Information Print This Page
Sign up for updates

About Erectile Dysfunction

If you have a problem getting or keeping an erection firm enough for sex, it's called erectile dysfunction (ED). This is a result of a lack of blood flow to the penis.

ED is more common than you think

About 30 million men in the United States have ED and ED affects men in different ways. Some men aren't able to get an erection at all. Others can get one, but it's not firm enough for sex. And some men get a firm erection but lose it before or during sex.

ED is a treatable medical condition. So for many men, treatment can help improve erections.

It is estimated that every year there will be over 600,000 new cases of ED in the US.


CAVERJECT is used to treat erectile dysfunction (ED) due to neurogenic, vasculogenic, psychogenic, or mixed etiology.


Important Safety Information

CAVERJECT should not be used in men hypersensitive to alprostadil, men with conditions that may predispose them to priapism (such as sickle cell anemia or trait, multiple myeloma or leukemia), men with anatomical deformities of the penis (such as angulation, cavernosal fibrosis or Peyronie’s disease), men with penile implants, or men for whom sexual activity is inadvisable or is contraindicated.

CAVERJECT should not be used in women, children or newborns.

Patients should be instructed to immediately report to his physician any erection lasting 4 hours or longer. If unavailable, patient must seek immediate medical assistance.

CAVERJECT can cause penile fibrosis or Peyronie’s disease.

Use of Caverject in patients who take anticoagulants, such as warfarin or heparin, should be with precaution as they may have increased tendency for bleeding after Caverject injections.

The most common side effect of CAVERJECT® (alprostadil for injection) was penile pain, reported by 37% of patients in clinical studies. Other side effects were prolonged erection, penile fibrosis and injection site hematoma. To lower the risk of prolonged erections or priapism, Caverject should be titrated slowly to the lowest effective dose.

For Full Prescribing and Patient Information for CAVERJECT®, please click here.